Blonder Tongue Laboratories, Inc.
BDRL
$0.0532
-$0.0068-11.33%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -2.92M | -3.94M | -3.44M | -656.00K | 84.00K |
| Total Depreciation and Amortization | 891.00K | 1.01M | 1.08M | 1.11M | 1.14M |
| Total Amortization of Deferred Charges | 123.00K | 121.00K | 121.00K | 145.00K | 168.00K |
| Total Other Non-Cash Items | 1.14M | 763.00K | 583.00K | -1.14M | -893.00K |
| Change in Net Operating Assets | -615.00K | -91.00K | -1.01M | -786.00K | -1.67M |
| Cash from Operations | -1.38M | -2.13M | -2.67M | -1.32M | -1.17M |
| Capital Expenditure | -48.00K | -54.00K | -40.00K | -33.00K | -31.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.00K | -7.00K | -7.00K | -21.00K | -55.00K |
| Cash from Investing | -55.00K | -61.00K | -47.00K | -54.00K | -86.00K |
| Total Debt Issued | 1.99M | 2.17M | 1.77M | 255.00K | 955.00K |
| Total Debt Repaid | -745.00K | -320.00K | 442.00K | 616.00K | -61.00K |
| Issuance of Common Stock | -- | 236.00K | 514.00K | 560.00K | 564.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.24M | 2.09M | 2.73M | 1.43M | 1.46M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.00K | -104.00K | 17.00K | 54.00K | 205.00K |